Monitoring the heart during cancer therapy
Habibian M, Lyon AR.
Eur Heart J Suppl. 2019 Dec;21(Suppl M):M44-M49. doi: 10.1093/eurheartj/suz230. Epub 2019 Dec 31.
CARDIONCOLOGY.ORG ABSTRACT:
Cancer therapies are often associated with cardiovascular (CV) toxicities as such the field of cardio-oncology has seen rapid evolution, and has initiated the use of monitoring through biomarkers as well as imaging to manage the cardiovascular system during and after treatment. This article reviews the strengths and weaknesses of different options and their impact on cardio-oncology care.
© All Rights Reserved